SNTI (Senti Biosciences Holdings) Total Liabilities: $36.51 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SNTI Senti Biosciences Holdings Inc SNTI
18 GF Score
Price $0.39
! 6 Warning Signs
View Full Analysis

What is Senti Biosciences Holdings Total Liabilities?

Senti Biosciences Holdings SNTI -1.15% 18 Total Liabilities is $36.51 Mil as of Jun. 2026. GuruFocus rates SNTI with a GF Score™ of 18/100. The stock has 6 warning signs investors should review.

Senti Biosciences Holdings's Total Liabilities for the quarter that ended in Jun. 2026 was $36.51 Mil.

Senti Biosciences Holdings's quarterly Total Liabilities declined from Dec. 2025 ($45.63 Mil) to Mar. 2026 ($35.68 Mil) but then increased from Mar. 2026 ($35.68 Mil) to Jun. 2026 ($36.51 Mil).

Senti Biosciences Holdings's annual Total Liabilities increased from Dec. 2023 ($52.57 Mil) to Dec. 2024 ($72.19 Mil) but then declined from Dec. 2024 ($72.19 Mil) to Dec. 2025 ($45.63 Mil).


Senti Biosciences Holdings Total Liabilities Historical Data

* Premium members only.

The historical data trend for Senti Biosciences Holdings's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Senti Biosciences Holdings Total Liabilities Chart

Senti Biosciences Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial 208.16 53.53 52.57 72.19 45.63

Senti Biosciences Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.89 44.56 45.63 35.68 36.51
SNTI
18GF Score
Senti Biosciences Holdings Inc SNTI
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Senti Biosciences Holdings Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Senti Biosciences Holdings's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=13.974+(23.561+0.149
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+7.95+0+0)
=45.63

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=51.223-5.589
=45.63

Senti Biosciences Holdings's Total Liabilities for the quarter that ended in Jun. 2026 is calculated as

Total Liabilities=Total Assets (Q: Jun. 2026 )-Total Equity (Q: Jun. 2026 )
=33.105--3.401
=36.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $36.51 Mil mean?
Senti Biosciences Holdings (SNTI) has a Total Liabilities of $36.51 Mil as of Jun. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Senti Biosciences Holdings and its competitors.
Is Senti Biosciences Holdings' Total Liabilities too high?
Senti Biosciences Holdings' current Total Liabilities is $36.51 Mil. Overall, Senti Biosciences Holdings has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Senti Biosciences Holdings' Total Liabilities compare to ZEOX and BCDA?
Senti Biosciences Holdings' Total Liabilities of $36.51 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Senti Biosciences Holdings and its competitors. Senti Biosciences Holdings's current Total Liabilities is $36.51 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Senti Biosciences Holdings stock overvalued right now?
Senti Biosciences Holdings (SNTI) has a current Total Liabilities of $36.51 Mil. The current Total Liabilities is $36.51 Mil. Senti Biosciences Holdings' overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Senti Biosciences Holdings (SNTI), the current Total Liabilities is $36.51 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Senti Biosciences Holdings Business Description

Address 2 Corporate Drive, First Floor, South San Francisco, CA, USA, 94080
Senti Biosciences Holdings Inc, formerly known as Senti Biosciences Inc, is a clinical-stage biotechnology company developing cell and gene therapies using its gene circuit platform for patients with incurable diseases. Its gene circuits, created from proprietary DNA sequences, are designed to reprogram cells to sense, compute, and respond to cellular environments. Its product candidates are to kill cancer cells, spare healthy cells, increase specificity, and control drug expression. Its candidate, SENTI-202, is a logic-gated off-the-shelf CAR-NK cell therapy for blood cancers, currently in a Phase 1 clinical trial in the United States and Australia for relapsed or refractory hematological malignancies, including Acute Myeloid Leukemia (AML).
18GF Score

Get the complete analysis for SNTI

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.39
Price